Active, not recruitingPhase 1NCT04255147

Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia

Studying Bronchopulmonary dysplasia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Ottawa Hospital Research Institute
Principal Investigator
Bernard Thébaud, MD, PhD
Ottawa Hospital Research Institute
Intervention
Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells(biological)
Enrollment
9 enrolled
Eligibility
All sexes
Timeline
2022 – 2033

Study locations (2)

Collaborators

Canadian Institutes of Health Research (CIHR) · Ontario Institute of Regenerative Medicine (OIRM) · Stem Cell Network

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04255147 on ClinicalTrials.gov

Other trials for Bronchopulmonary dysplasia

Additional recruiting or active studies for the same condition.

See all trials for Bronchopulmonary dysplasia →

← Back to all trials